Hepatitis C Drug Market Analysis, Segments, Growth and Value Chain 2021

Deerfield Beach, FL -- (SBWire) -- 08/17/2016 --Zion Research has published a new report titled "Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021" According to the report, global demand for hepatitis C drug market was valued at USD 11.81 billion in 2015, is expected to reach USD 27.63 billion in 2021 and is anticipated to grow at a CAGR of 17% between 2016 and 2021.

HCV is a major public health problem that attacks the liver and leads to inflammation. Certain drugs, toxins, heavy alcohol use, bacterial and viral infections can cause hepatitis infection. The most common types of hepatitis infections are Hepatitis A, Hepatitis B, and Hepatitis C and they are caused by three dissimilar dissimilar viruses. Although each virus can cause similar symptoms, they have different modes of transmission and can affect the liver differently. Hepatitis C infection can bring both acute and chronic hepatitis disease. Approximately, 80% of patients get chronically infected with hepatitis C disease. Hepatitis C infection (HCV) spreads through the blood of infected individual by the use of shared needles or supplies used to infuse drugs. Vaccines are available only for Hepatitis A and Hepatitis B viruses. Research into the development of a vaccine for hepatitis C is under way.

Browse the full "Hepatitis C Drug Market for (Hospitals, Private Labs, Physician Offices, Public Health Labs and Blood Banks) by Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423

The prevalence of the infection, new productive treatments, relatively lesser time of treatment from before, and rising government subsidizing, can drive the hepatitis C drug market. Lack of awareness and information about HCV and treatment expense of disease can influence the hepatitis C market. In the last few years a couple of new drugs have been launched in the market which has huge success and captured maximum market share of the hepatitis C market. However, cost of these drugs is too high. Hospitals, private labs, physician offices, public health labs, and blood banks are the key application of hepatitis C drug market.

Get Free Sample Report: http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423#RequestSample

North America was one of the fastest growing hepatitis C drug markets across the world with more than 40% share of the total revenue generated in 2015. U. S. is the largest revenue contributor for worldwide Hepatitis C market. Government funding for drug development will continue to play an essential role in the growth of U.S. HCV treatment market. Europe was the second major market for Hepatitis C in 2015.

Ongoing research and development in pharmaceutical industry for hepatitis C drug development is expected to propel the market growth in the coming years. Moreover, interest for Hepatitis C medication is expanding in Asia Pacific, Latin America and Middle East and Africa due to prevalence of the disease in the regions combined with expenditure on healthcare infrastructure.

Read Detail TOC: http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423#tableOfContent

Harvoni and Sovaldi are newly discovered drugs for Hepatitis C. Marketed by pharmaceutical giant Gilead Sciences and has more than 95% cure rate. The problem with this drug is its high cost, Harvoni drug is one of the expensive drug in the world. Some of the key player in the hepatitis C drug market includes Merck & Co, Kenilworth, Roche, Basel GlaxoSmith, Gilead Sciences, AbbVie, Johnson & Johnson and Bristol-Myers Squibb.

Inquiry Before Buying: http://www.marketresearchstore.com/report/hepatitis-c-drug-market-z62423#InquiryForBuying

The report segments the global hepatitis C drug market as:

Hepatitis C Drug Market: Application Segment Analysis
Hospitals
Private labs
Physician offices
Public health labs
Blood banks

Hepatitis C Drug Market: Regional Segment Analysis
North America
U.S.
Europe
Germany
UK
France
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa

About Zion Research
Zion Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Zion Research experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each Zion Research syndicated research report covers a different sector — such as pharmaceuticals, chemical, energy, food and beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports strive to serve the overall research requirement of clients.

Contact US:
Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@marketresearchstore.com
Website: http://www.marketresearchstore.com